tolerability


Also found in: Thesaurus, Idioms, Wikipedia.

tol·er·a·ble

 (tŏl′ər-ə-bəl)
adj.
1. Capable of being tolerated; endurable: found the workload tolerable and so kept the job.
2. Acceptable but not superior; passable: "This encouraged me to think I might possibly in time come to be a tolerable English writer" (Benjamin Franklin). See Synonyms at average.

tol′er·a·bil′i·ty, tol′er·a·ble·ness n.
tol′er·a·bly adv.
References in periodicals archive ?
Tonix Pharmaceuticals announced that participants were dosed in a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of TNX-601 for the daytime treatment of posttraumatic stress disorder.
--Diroximel Fumarate Demonstrated Statistically Superior Gastrointestinal (Gl) Tolerability on EVOLVE-MS-2 Study's Primary Endpoint Assessing Self-Reported Gl Events--
This ongoing Phase 1/2a multicentre, open-label study is expected to take place at 15 sites in the US, UK and Israel in two parts to evaluate the safety and tolerability of AGI-134, given both as monotherapy and in combination with an immune checkpoint inhibitor, in solid tumours.
For patients who have never taken aripiprazole, "establish tolerability with oral aripiprazole prior to initiating treatment with Aristada.
The objectives of the study are to evaluate the safety, tolerability and preliminary efficacy of this combination in patients with treatment-resistant solid tumors.
(Japan) announced the recent publication of an original research study on the "Safety and Tolerability of Dr.
A new study shows that ResistAid, a proprietary immune ingredient from Lonza has very good tolerability. The randomized, double-blind, placebo-controlled clinical trial was published in the November issue of Food and Nutrition Sciences (Vol.
Abstract: Objective To compare the efficacy and tolerability of topical adapalene gel 0.1% with isotretinoin gel 0.05% in treatment of mild to moderate acne vulgaris.
Tolerability and safety of this drug has already been established in cats with heart disease.
Secondary objectives were the local and systemic tolerability, the influence on tumor remission and the influence on the 1-year recurrence rate.
The so-called Bravo study was designed to evaluate the efficacy, safety and tolerability of oral laquinimod in comparison with placebo.